UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology

British journal of cancer, 2011-11, Vol.105 (10), p.1608-1614

2011

Volltextzugriff (PDF)

TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients

British journal of cancer, 2014-03, Vol.110 (6), p.1545-1551

2014

Volltextzugriff (PDF)

Empirical rescue therapy after Helicobacter pylori treatment failure: a 10‐year single‐centre study of 500 patients

Alimentary pharmacology & therapeutics, 2008-02, Vol.27 (4), p.346-354

2008

Volltextzugriff (PDF)

Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail

Alimentary pharmacology & therapeutics, 2002-06, Vol.16 (6), p.1047-1057

2002

Volltextzugriff (PDF)

Third‐line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures

Alimentary pharmacology & therapeutics, 2006-11, Vol.24 (10), p.1469-1474

2006

Volltextzugriff (PDF)

Systematic review and meta‐analysis: is 1‐week proton pump inhibitor‐based triple therapy sufficient to heal peptic ulcer?

Alimentary pharmacology & therapeutics, 2005-04, Vol.21 (7), p.795-804

2005

Volltextzugriff (PDF)

Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value

Tumor biology, 2016-10, Vol.37 (10), p.13687-13694

2016

Volltextzugriff (PDF)

Helicobacter pylori first‐line treatment and rescue options in patients allergic to penicillin

Alimentary pharmacology & therapeutics, 2005-11, Vol.22 (10), p.1041-1046

2005

Volltextzugriff (PDF)

Helicobacter pylori ‘rescue’ regimen when proton pump inhibitor‐based triple therapies fail

Alimentary pharmacology & therapeutics, 2002-06, Vol.16 (6), p.1047-1057

2002

Volltextzugriff (PDF)

Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma

Oral diseases, 2015-10, Vol.21 (7), p.899-904

2015

Volltextzugriff (PDF)

Recurrence of Helicobacter pylori infection after several eradication therapies: long‐term follow‐up of 1000 patients

Alimentary pharmacology & therapeutics, 2006-03, Vol.23 (6), p.713-719

2006

Volltextzugriff (PDF)

Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta‐analysis of eradication of Helicobacter pylori

Alimentary pharmacology & therapeutics, 2000-10, Vol.14 (10), p.1319-1328

2000

Volltextzugriff (PDF)

Proton pump inhibitors versus H2‐antagonists: a meta‐analysis of their efficacy in treating bleeding peptic ulcer

Alimentary pharmacology & therapeutics, 2001-07, Vol.15 (7), p.917-926

2001

Volltextzugriff (PDF)

Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection

Alimentary pharmacology & therapeutics, 2005-03, Vol.21 (6), p.653-662

2005

Volltextzugriff (PDF)

Meta‐analysis: proton pump inhibitors vs. H2‐receptor antagonists — their efficacy with antibiotics in Helicobacter pylori eradication

Alimentary pharmacology & therapeutics, 2003-10, Vol.18 (8), p.757-766

2003

Volltextzugriff (PDF)

Evaluation of three different tests for the detection of stool antigens to diagnose Helicobacter pylori infection in patients with upper gastrointestinal bleeding

Alimentary pharmacology & therapeutics, 2004-04, Vol.19 (8), p.923-929

2004

Volltextzugriff (PDF)

A blood-tumor barrier limits gene transfer to experimental liver cancer: the effect of vasoactive compounds

Gene therapy, 2000-11, Vol.7 (21), p.1824-1832

2000

Volltextzugriff (PDF)

Seven‐day ‘rescue’ therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole

Alimentary pharmacology & therapeutics, 1999-10, Vol.13 (10), p.1311-1316

1999

Volltextzugriff (PDF)

Helicobacter pylori and Bleeding Peptic Ulcer: What is the Prevalence of the Infection in Patients with this Complication?

Scandinavian journal of gastroenterology, 2003-01, Vol.38 (1), p.2-9

2003

Volltextzugriff (PDF)

Systematic review: rabeprazole-based therapies in Helicobacter pylori eradication

Alimentary pharmacology & therapeutics, 2003-03, Vol.17 (6), p.751-764

2003

Volltextzugriff (PDF)

Characterization through whole exome sequencing of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced non-small lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29, p.viii651-viii652

2018

Volltextzugriff (PDF)

Esomeprazole-based therapy in Helicobacter pylori eradication: a meta-analysis

Digestive and liver disease, 2004-04, Vol.36 (4), p.253-259

2004

Volltextzugriff (PDF)

H. pylori-negative duodenal ulcer prevalence and causes in 774 patients

Digestive diseases and sciences, 1999-11, Vol.44 (11), p.2295-2302

1999

Volltextzugriff (PDF)

Helicobacter pylori Disrupts Epithelial Barrier Function in a Process Inhibited by Protein Kinase C Activators

Infection and Immunity, 1998-06, Vol.66 (6), p.2943-2950

1998

Volltextzugriff (PDF)

H pylori infection is associated with downregulation of E-cadherin, a molecule involved in epithelial cell adhesion and proliferation control

Journal of clinical pathology, 1998-05, Vol.51 (5), p.410-412

1998

Volltextzugriff (PDF)

1 – 25 von 1.341

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.143)
Mit Volltextzugriff
(1.052)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology

TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients

Empirical rescue therapy after Helicobacter pylori treatment failure: a 10‐year single‐centre study of 500 patients

Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail

Third‐line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures

Systematic review and meta‐analysis: is 1‐week proton pump inhibitor‐based triple therapy sufficient to heal peptic ulcer?

Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value

Helicobacter pylori first‐line treatment and rescue options in patients allergic to penicillin

Helicobacter pylori ‘rescue’ regimen when proton pump inhibitor‐based triple therapies fail

Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma

Recurrence of Helicobacter pylori infection after several eradication therapies: long‐term follow‐up of 1000 patients

Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta‐analysis of eradication of Helicobacter pylori

Proton pump inhibitors versus H2‐antagonists: a meta‐analysis of their efficacy in treating bleeding peptic ulcer

Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection

Meta‐analysis: proton pump inhibitors vs. H2‐receptor antagonists — their efficacy with antibiotics in Helicobacter pylori eradication

Evaluation of three different tests for the detection of stool antigens to diagnose Helicobacter pylori infection in patients with upper gastrointestinal bleeding

A blood-tumor barrier limits gene transfer to experimental liver cancer: the effect of vasoactive compounds

Seven‐day ‘rescue’ therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole

Helicobacter pylori and Bleeding Peptic Ulcer: What is the Prevalence of the Infection in Patients with this Complication?

Systematic review: rabeprazole-based therapies in Helicobacter pylori eradication

Characterization through whole exome sequencing of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced non-small lung cancer (NSCLC)

Esomeprazole-based therapy in Helicobacter pylori eradication: a meta-analysis

H. pylori-negative duodenal ulcer prevalence and causes in 774 patients

Helicobacter pylori Disrupts Epithelial Barrier Function in a Process Inhibited by Protein Kinase C Activators

H pylori infection is associated with downregulation of E-cadherin, a molecule involved in epithelial cell adhesion and proliferation control

Suchergebnisse filtern